PolyPid reports a narrower Q1 GAAP loss, beating estimates by $0.08 as cash reserves extend operational runway into late 2026.
PolyPid reported a Q1 GAAP loss of $0.35 per share, narrower than the expected loss by $0.08. The result reflects improved financial performance amid ongoing operational adjustments.
Cash reserves stood at $10.9 million as of March 31, 2026, down from $12.9 million at the end of 2025. The company stated its current liquidity will support operations into the second half of 2026, aligning with key upcoming milestones.
No immediate market reaction was disclosed in the release.